Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1151056

Positive airway pressure (PAP) treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients with concomitant weight loss: Longitudinal data from the ESADA


(ESADA Study Group) (ESADA study group) Tasbakan, Mehmet Sezai; Grote, Ludger; Hedner, Jan; ...; Đogaš, Zoran; ...et al.
Positive airway pressure (PAP) treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients with concomitant weight loss: Longitudinal data from the ESADA // Journal of sleep research, 30 (2021), 5; e13331, 11 doi:10.1111/jsr.13331. (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1151056 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Positive airway pressure (PAP) treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients with concomitant weight loss: Longitudinal data from the ESADA

Autori
(ESADA study group) Tasbakan, Mehmet Sezai ; Grote, Ludger ; Hedner, Jan ; ... ; Đogaš, Zoran ; ...et al.

Kolaboracija
ESADA Study Group

Izvornik
Journal of sleep research (0962-1105) 30 (2021), 5; E13331, 11

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
HbA1c ; positive airway pressure therapy ; sleep apnea.

Sažetak
Patients with obstructive sleep apnea (OSA) are at increased risk of developing metabolic disease such as diabetes. The effects of positive airway pressure on glycemic control are contradictory. We therefore evaluated the change in glycated hemoglobin (HbA1c) in a large cohort of OSA patients after long-term treatment with positive airway pressure. HbA1c levels were assessed in a subsample of the European Sleep Apnea Database [n=1608] at baseline and at long-term follow up with positive airway pressure therapy (mean 378.9±423.0 days). In a regression analysis, treatment response was controlled for important confounders. Overall, HbA1c decreased from 5.98±1.01% to 5.93±0.98% (p=0.001). Patient subgroups with a more pronounced HbA1c response included patients with diabetes (-0.15±1.02, p=0.019), those with severe OSA baseline (-0.10±0.68, p=0.005), those with morbid obesity (-0.20±0.81, p<0.001). The strongest HbA1c reduction was observed in patients with a concomitant weight reduction >5 kilos (-0.38±0.99, p<0.001). In robust regression analysis, severe OSA (p=0.038) and morbid obesity (p=0.005) at baseline, and weight reduction >5 kilos (p<0.001) during follow up were independently associated with a reduction of HbA1c following PAP treatment. In contrast, PAP treatment alone without weight reduction was not associated with significant Hb1Ac reduction. In conclusion, positive airway pressure therapy is associated with HbA1c reduction in patients with severe OSA, in morbidly obese patients. and most obviously in those with significant weight lost during the follow-up. Our study underlines the importance to combine positive airway pressure use with adjustments in lifestyle to substantially modify metabolic complications in OSA.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Split

Profili:

Avatar Url Zoran Đogaš (autor)

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

(ESADA Study Group) (ESADA study group) Tasbakan, Mehmet Sezai; Grote, Ludger; Hedner, Jan; ...; Đogaš, Zoran; ...et al.
Positive airway pressure (PAP) treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients with concomitant weight loss: Longitudinal data from the ESADA // Journal of sleep research, 30 (2021), 5; e13331, 11 doi:10.1111/jsr.13331. (međunarodna recenzija, članak, znanstveni)
(ESADA Study Group) (ESADA Study Group) (ESADA study group) Tasbakan, M., Grote, L., Hedner, J., ..., Đogaš, Z. & ...et al. (2021) Positive airway pressure (PAP) treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients with concomitant weight loss: Longitudinal data from the ESADA. Journal of sleep research, 30 (5), e13331, 11 doi:10.1111/jsr.13331..
@article{article, author = {(ESADA study group) Tasbakan, Mehmet Sezai and Grote, Ludger and Hedner, Jan and \DJoga\v{s}, Zoran}, year = {2021}, pages = {11}, DOI = {10.1111/jsr.13331.}, chapter = {e13331}, keywords = {HbA1c, positive airway pressure therapy, sleep apnea.}, journal = {Journal of sleep research}, doi = {10.1111/jsr.13331.}, volume = {30}, number = {5}, issn = {0962-1105}, title = {Positive airway pressure (PAP) treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients with concomitant weight loss: Longitudinal data from the ESADA}, keyword = {HbA1c, positive airway pressure therapy, sleep apnea.}, chapternumber = {e13331} }
@article{article, author = {(ESADA study group) Tasbakan, Mehmet Sezai and Grote, Ludger and Hedner, Jan and \DJoga\v{s}, Zoran}, year = {2021}, pages = {11}, DOI = {10.1111/jsr.13331.}, chapter = {e13331}, keywords = {HbA1c, positive airway pressure therapy, sleep apnea.}, journal = {Journal of sleep research}, doi = {10.1111/jsr.13331.}, volume = {30}, number = {5}, issn = {0962-1105}, title = {Positive airway pressure (PAP) treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients with concomitant weight loss: Longitudinal data from the ESADA}, keyword = {HbA1c, positive airway pressure therapy, sleep apnea.}, chapternumber = {e13331} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font